Tag:
Itero Biopharmaceuticals
Latest Headlines
Latest Headlines
Developers zero in on the new 'bio-better' strategy
The Wall Street Journal's venture blog focuses on three upstart biotechs plotting to push programs on new "bio-betters," essentially second-gen biologics that can pull the market rug out from under
Vax proves out 3-leg business model
Xcellerex's yellow fever vaccine is about to be tested in a Phase I study, marking a clinical-phase milestone for the company. The accomplishment also helps validate the company's disposable
Itero finds synergy in Xcellerex
The combination of disposable technology, contract manufacturing capabilities, and a development partner has led specialty biopharma Itero, in San Mateo, CA, to join forces with opposite-coast
